Publications by authors named "Luca Barca"
Article Synopsis
- Risk stratification for patients with drug-induced type-1 Brugada syndrome is difficult, and the usefulness of electrophysiological studies (EPS) is unclear.
- A systematic literature search categorized patients into three groups based on EPS results: positive, negative, and no EPS conducted.
- The study found no significant differences in the rates of arrhythmia events among these groups over an average follow-up of 5.1 years, suggesting EPS may not enhance long-term prognosis in these patients.
Cardiogenic shock with acute hemodynamic decompensation may be one of the most serious risks in patients affected by ventricular tachycardia (VT). Its proper identification may have important implications in terms of pharmacological management, as might procedural planning in case of patients undergoing catheter ablation. We describe a case series of patients with provisional strategies for circulatory support in VT ablation, including the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) and vascular accesses in the electrophysiology lab but no initial ECMO activation due to an estimated intermediate pre-procedural risk from the case-series population.
View Article and Find Full Text PDFBackground: The gold standard for the treatment of cardiac implantable electronic devices (CIEDs)-related infection and lead malfunction is transvenous lead extraction (TLE). To date, the risk of mortality directly related to TLE procedures is relatively low, but data on post-procedural and long-term mortality are limited, even more in the aging population.
Methods: Consecutive patients with CIEDs who underwent TLE were retrospectively studied.